Stephan Schreiber

Investment Associate at Elevat3 Capital
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
UK

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United Kingdom
    • Venture Capital and Private Equity Principals
    • 1 - 100 Employee
    • Investment Associate
      • Jan 2020 - Present

      Elevat3 Capital is the venture capital arm of serial entrepreneur and investor Christian Angermayer and his family office Apeiron Investment Group. With a focus on Europe, the firm partners with companies that meet its three-level investment criteria, then elevates them by providing more than just capital. Elevat3 primarily invests in exciting ventures in life sciences, fintech and deep tech. Elevat3 Capital is the venture capital arm of serial entrepreneur and investor Christian Angermayer and his family office Apeiron Investment Group. With a focus on Europe, the firm partners with companies that meet its three-level investment criteria, then elevates them by providing more than just capital. Elevat3 primarily invests in exciting ventures in life sciences, fintech and deep tech.

    • Malta
    • Venture Capital and Private Equity Principals
    • 1 - 100 Employee
    • Investment Associate
      • Jun 2019 - Present

      Apeiron Investment Group is the family office of serial entrepreneur and investor Christian Angermayer. The firm invests in all stages of a company’s life cycle from non-listed seed investments to large size restructurings and special situations deals and uses its exceptional network of partners to build bridges between business, politics, arts, science and technology. Apeiron Investment Group is the family office of serial entrepreneur and investor Christian Angermayer. The firm invests in all stages of a company’s life cycle from non-listed seed investments to large size restructurings and special situations deals and uses its exceptional network of partners to build bridges between business, politics, arts, science and technology.

    • Germany
    • Biotechnology Research
    • 1 - 100 Employee
    • Investment & Venture Development Intern
      • Feb 2019 - Jul 2019

Community

You need to have a working account to view this content. Click here to join now